688606 Hangzhou Alltest Biotech
- 68.75
- -0.58-0.84%
Hangzhou Alltest Biotech News
Notice on the progress of voluntary disclosure of foreign investment industrial funds
Aotai Biotech: Announcement of Resolutions of the 9th Meeting of the 3rd Board of Supervisors
Aotai Biotech: Announcement of Resolutions of the 9th Meeting of the 3rd Board of Directors
Aotai Biotech: Shenzhen Value Online Consulting Co., Ltd.\'s independent financial advisory report on how Hangzhou Aotai Biotechnology Co., Ltd. was granted for the first time in the 2022 Restricted Stock Incentive Plan to meet the eligibility requirements for the second vesting period
Aotai Biotech: Legal Opinion of Shanghai Lifeng Law Firm on Hangzhou Aotai Biotechnology Co., Ltd.\'s 2022 Restricted Stock Incentive Plan Grant Price Adjustment, Achievement of Ownership Conditions for the First Second Vesting Period, and Cancellation of Some Restricted Shares
Aotai Biotech: Third quarter report 2024
Aotai Biotech: Announcement on holding the results briefing for the third quarter of 2024
Aotai Biotech: Announcement on Cancelling Some Restricted Stocks in the 2022 Restricted Stock Incentive Plan
Aotai Biotech: Announcement on adjusting the price granted under the 2022 Restricted Stock Incentive Plan
Aotai Biotech: Opinions of the Supervisory Board of Hangzhou Aotai Biotechnology Co., Ltd. on the verification of the company\'s 2022 restricted stock incentive plan for the first time granting an ownership list for the second vesting period
Aotai Biotech: Announcement on granting a second vesting period for the first time in the 2022 Restricted Stock Incentive Plan to meet the requirements of ownership
Announcement on the abolition of some restricted stocks in the 2022 Restricted Stock Incentive Plan
Third Quarter Report 2024
Announcement of Resolutions of the 9th Meeting of the Third Board of Supervisors
Announcement on the adjustment of the price granted under the 2022 Restricted Stock Incentive Plan
Shenzhen Value Online Consulting Co., Ltd.\'s independent financial advisory report on how Hangzhou Aotai Biotechnology Co., Ltd. was granted for the first time in the 2022 Restricted Stock Incentive Plan to meet the eligibility requirements for the second vesting period
Legal Opinion of Shanghai Lifeng Law Firm on Hangzhou Aotai Biotechnology Co., Ltd.\'s 2022 Restricted Stock Incentive Plan Grant Price Adjustment, Achievement of Ownership Conditions for the First Second Vesting Period, and Cancellation of Some Restricted Shares
Opinions of the board of supervisors of Hangzhou Aotai Biotechnology Co., Ltd. on the verification of the ownership list for the first time granted by the company\'s 2022 restricted stock incentive plan for the second vesting period
Announcement on granting a second vesting period for the first time in the 2022 Restricted Stock Incentive Plan to meet the eligibility requirements
Announcement of Resolutions of the 9th Meeting of the Third Board of Directors
Analysis
Price Target
No Data
No Data